Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592058 · ClinicalTrials.gov registry record
Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period
A clinical trial of Weight Change, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 427
- Enrollment target
- 1
- Study location
NCT01592058: Completed study of Weight Change, sponsored by Washington University School of Medicine.
NCT01592058 is a study of Weight Change that has completed, run by Washington University School of Medicine. The registered enrollment target is 427 participants, above the 248-participant average among 3 other Weight Change trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01592058, a study of Weight Change, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 427 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard). The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.
Primary Outcome
Change in weight from baseline at 12 months.
Conditions Studied
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 427 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-05 |
What the finished NCT01592058 record still lists
NCT01592058 is an observational study that tracks outcomes without assigning an intervention. The registered 427 participants enrollment target is mid-sized for trials with a published cap, above the 248-participant average among 3 other Weight Change trials with a reported enrollment target (72% higher).
The record links to 1 condition, with Weight Change appearing as the primary indexed condition, and to 0 interventions.
NCT01592058 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01592058 about?
NCT01592058 is a clinical study titled "Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period". The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormon...
What is the current status of trial NCT01592058?
This trial is currently completed. The enrollment target is 427 participants. The study started on 2010-06. Estimated completion is 2012-05.
What conditions does trial NCT01592058 study?
This clinical trial studies the following conditions: Weight Change.
Who is sponsoring clinical trial NCT01592058?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01592058 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Change
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia